Table 1 Clinicopathological characteristics of enrolled patients.
From: Short-term outcomes comparison of KangDuo 2.0 and Da Vinci Xi in radical cystectomy
Baseline characteristics | DV group (n = 18) | KD group (n = 16) | p |
|---|---|---|---|
Age | 0.6077 | ||
Mean ± SD | 65.67 ± 7.96 | 63.88 ± 12.00 | |
Sex (n %) | |||
Male | 11(61.11%) | 12(75.00%) | 0.4768 |
Female | 7(38.89%) | 4(25.00%) | |
KPS | 0.5363 | ||
Median | 90.00 | 90.00 | |
Q1,Q3 | 90.00,90.00 | 90.00,90.00 | |
TNM stage (n %) | 0.0349 | ||
T2 | 13(72.22%) | 6(37.50%) | |
T3 | 4(22.22%) | 10(62.50%) | |
T4 | 1(5.56%) | 0(0.00%) | |
BMI | 0.2335 | ||
Median | 21.50 | 22.30 | |
Q1,Q3 | 19.80,24.00 | 21.55,23.75 | |
Past medical history (n %) | 1.0000 | ||
TURBT | 5(27.78%) | 6(37.50%) | |
TURBT and Neoadjuvant therapy | 3(16.67%) | 2(12.50%) | |
None | 9(50.00%) | 8(50.00%) | |
Neoadjuvant therapy | 1(5.56%) | 0(0.00%) | |
Comorbidity (n %) | 0.2311 | ||
Hypertension | 8(44.44%) | 4(25.00%) | |
Cardiovascular disease | 0(0.00%) | 1(6.25%) | |
Diabetes | 0(0.00%) | 2(12.50%) | |
None | 9(50.00%) | 9(56.25%) | |
Pneumonia | 1(5.56%) | 0(0.00%) | |
ASA stage (n %) | 1.0000 | ||
I | 3(16.67%) | 3(18.75%) | |
II | 15(83.33%) | 13(81.25%) | |
